Encenicline (EVP6124), which is a mixed α7 nAChR agonist/5HT3 antagonist, showed significant clinical improvement on PANSS cognitive impairment domain and also for the PANSS negative scale [153]. The gene discussed is CHRNA7; the disease is Cognitive impairment.